Development of a Discriminative Dissolution Method, Using In-Silico Tool for Hydrochlorothiazide and Valsartan Tablets

Hydrochlorothiazide (HTZ) and Valsartan (VAL) are poorly soluble drugs in BCS classes IV and II. This study aimed to develop a method to assess the dissolution profile of tablets containing HTZ (12.5 mg) and VAL (160 mg) as a fixed-dose combination, using in silico tools to evaluate products markete...

Descripción completa

Detalles Bibliográficos
Autores principales: Leon, Rosmery Merma, Issa, Michele Georges, Duque, Marcelo Dutra, Daniel, Josiane Souza Pereira, Ferraz, Humberto Gomes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301187/
https://www.ncbi.nlm.nih.gov/pubmed/37376183
http://dx.doi.org/10.3390/pharmaceutics15061735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301187/
https://www.ncbi.nlm.nih.gov/pubmed/37376183
http://dx.doi.org/10.3390/pharmaceutics15061735

Ejemplares similares